发明名称 |
SUBSTITUTED DIAMINOPYRIMIDYL COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH |
摘要 |
Provided herein are diaminopyrimidyl Compounds having the following structures:;wherein X, L, R1, and R2 are as defined herein, compositions comprising an effective amount of a Diaminopyrimidyl Compound, and methods for treating or preventing PKC-theta-mediated disorders, or a condition treatable or preventable by inhibition of a kinase, for example, PKC-theta. |
申请公布号 |
US2016354374(A1) |
申请公布日期 |
2016.12.08 |
申请号 |
US201615241232 |
申请日期 |
2016.08.19 |
申请人 |
Signal Pharmaceuticals, LLC |
发明人 |
Papa Patrick;Cathers Brian Edwin;CALABRESE Andrew Antony;WHITEFIELD Brandon Wade;BENNETT Brydon;CASHION Daniel;MORTENSEN Deborah;HUANG Dehua;TORRES Eduardo;PARNES Jason;SAPIENZA John;HANSEN Joshua;LEFTHERIS Katerina;CORREA Matthew;DELGADO Maria Mercedes;RAHEJA Raj K.;BAHMANYAR Sogole;HEGDE Sayee;NORRIS Stephen;PLANTEVIN-KRENITSKY Veronique |
分类号 |
A61K31/506;A61K31/5377;A61K31/505 |
主分类号 |
A61K31/506 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method for the treatment or prevention of PKC-theta mediated disorder comprising administering to a subject in need thereof an effective amount of a compound of formula (I): or a pharmaceutically acceptable salt, tautomer, or stereoisomer thereof, wherein: X is CN or CF3; L is (C1-4 alkyl); R1 is substituted or unsubstituted heteroaryl; and R2 is substituted or unsubstituted cycloalkyl, wherein the PKC-theta mediated disorder is graft-versus-host disease, organ transplant rejection, psoriasis, Duchenne muscular dystrophy, rheumatoid arthritis, insulin resistance, myasthenia gravis, multiple sclerosis, colitis, psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, Sjogren syndrome, asthma, or lupus. |
地址 |
San Diego CA US |